Can Glucose Metabolism Be Used as a Biomarker in Toxicology?
Yes, alterations in glucose metabolism can serve as a biomarker for exposure to certain toxicants. For example, elevated blood glucose levels may indicate exposure to toxicants that induce insulin resistance, while changes in the levels of metabolic intermediates can provide clues about specific pathway disruptions. Using these biomarkers, it is possible to assess the impact of chemical exposures and potentially guide therapeutic interventions.
